136 related articles for article (PubMed ID: 30536104)
1. Mouse Model for Hepatocellular Carcinoma and Cholangiocarcinoma Originated from Mature Hepatocytes.
Yamamoto M; Xin B; Nishikawa Y
Methods Mol Biol; 2019; 1905():221-236. PubMed ID: 30536104
[TBL] [Abstract][Full Text] [Related]
2. A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection.
Yu S; Vernia S
Methods Mol Biol; 2020; 2164():129-143. PubMed ID: 32607890
[TBL] [Abstract][Full Text] [Related]
3. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
4. Oncogene-Driven Induction of Orthotopic Cholangiocarcinoma in Mice.
Plantureux C; Paillet J; Autret G; Pérez-Lanzón M; Kroemer G; Maiuri MC; Pol J
Methods Mol Biol; 2024; 2769():99-108. PubMed ID: 38315392
[TBL] [Abstract][Full Text] [Related]
5. A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Xu RC; Wang F; Sun JL; Abuduwaili W; Zhang GC; Liu ZY; Liu TT; Dong L; Shen XZ; Zhu JM
J Transl Med; 2022 Dec; 20(1):579. PubMed ID: 36494846
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.
Özdemir BH
Exp Clin Transplant; 2023 Apr; 21(4):291-298. PubMed ID: 35297332
[TBL] [Abstract][Full Text] [Related]
7. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
8. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.
Baudhuin LM; Roberts LR; Enders FT; Swanson RL; Mettler TA; Aderca I; Stadheim LM; Highsmith WE
J Cancer Res Clin Oncol; 2006 Mar; 132(3):159-62. PubMed ID: 16292541
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
10. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Scholz A; Wiedenmann B; Miller LJ; Reubi JC
J Hepatol; 2006 Dec; 45(6):825-35. PubMed ID: 16935383
[TBL] [Abstract][Full Text] [Related]
11. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.
Wang G; Wang Q; Liang N; Xue H; Yang T; Chen X; Qiu Z; Zeng C; Sun T; Yuan W; Liu C; Chen Z; He X
Cell Death Dis; 2020 May; 11(5):313. PubMed ID: 32366840
[TBL] [Abstract][Full Text] [Related]
13. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF
World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611
[TBL] [Abstract][Full Text] [Related]
15. Hydrodynamic Transfection of Hepatocytes for the Study of Hepatocellular Carcinogenesis.
Ursic-Bedoya J; Gregoire D
Methods Mol Biol; 2024; 2769():77-85. PubMed ID: 38315390
[TBL] [Abstract][Full Text] [Related]
16. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
[TBL] [Abstract][Full Text] [Related]
19.
Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of Cas9 stably expressed human hepatocellular carcinoma and cholangiocarcinoma cell lines].
Zuo CX; Bian XC; Yang ZL; Feng HL; Zhou FY; Liu YQ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):572-579. PubMed ID: 30139026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
